Inhibrx financial statements

인히브릭스 바이오사이언시스NASDAQ:INBX · Nasdaq · Healthcare · sector #17
$93.41-1.22%
2026-10-06 close

Inhibrx's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was $1.69B.

Reported results

Inhibrx notifications

Quantus Signal · live data · not investment advice · Privacy Policy